Coronavirus Update: Moderna’s Omicron Vaccine Study Successful, But Data Draw Skepticism

Moderna announced results from the Phase II/III study of its mRNA-1273.214 vaccine candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip